Reservoirs of resistance: polymyxin resistance in veterinary‐associated companion animal isolates of <i>Pseudomonas aeruginosa</i>
-
- Andrea Scott
- Institute of Infection and Global Health, University of Liverpool Liverpool UK
-
- Sian Pottenger
- Institute of Infection and Global Health, University of Liverpool Liverpool UK
-
- Dorina Timofte
- Institute of Veterinary Science, University of Liverpool Neston Wirral UK
-
- Matthew Moore
- Institute of Infection and Global Health, University of Liverpool Liverpool UK
-
- Laura Wright
- Institute of Infection and Global Health, University of Liverpool Liverpool UK
-
- Irena Kukavica‐Ibrulj
- Université Laval Quebec City Quebec Canada
-
- Julie Jeukens
- Université Laval Quebec City Quebec Canada
-
- Roger C Levesque
- Université Laval Quebec City Quebec Canada
-
- Luca Freschi
- Université Laval Quebec City Quebec Canada
-
- Gina L Pinchbeck
- Institute of Infection and Global Health, University of Liverpool Liverpool UK
-
- Vanessa M Schmidt
- Institute of Infection and Global Health, University of Liverpool Liverpool UK
-
- Neil McEwan
- Institute of Veterinary Science, University of Liverpool Neston Wirral UK
-
- Alan D Radford
- Institute of Infection and Global Health, University of Liverpool Liverpool UK
-
- Joanne L Fothergill
- Institute of Infection and Global Health, University of Liverpool Liverpool UK
この論文をさがす
説明
<jats:sec><jats:title>Background</jats:title><jats:p><jats:italic>Pseudomonas aeruginosa</jats:italic> is an opportunistic pathogen and a major cause of infections. Widespread resistance in human infections are increasing the use of last resort antimicrobials such as polymyxins. However, these have been used for decades in veterinary medicine. Companion animals are an understudied source of antimicrobial resistant <jats:italic>P. aeruginosa</jats:italic> isolates. This study evaluated the susceptibility of <jats:italic>P. aeruginosa</jats:italic> veterinary isolates to polymyxins to determine whether the veterinary niche represents a potential reservoir of resistance genes for pathogenic bacteria in both animals and humans.</jats:p></jats:sec><jats:sec><jats:title>Methods and results</jats:title><jats:p>Clinical <jats:italic>P. aeruginosa</jats:italic> isolates (n=24) from UK companion animals were compared for antimicrobial susceptibility to a panel of human‐associated isolates (n=37). Minimum inhibitory concentration (MIC) values for polymyxin B and colistin in the companion animals was significantly higher than in human isolates (P=0.033 and P=0.013, respectively). Genotyping revealed that the veterinary isolates were spread throughout the <jats:italic>P. aeruginosa</jats:italic> population, with shared array types from human infections such as keratitis and respiratory infections, suggesting the potential for zoonotic transmission. Whole genome sequencing revealed mutations in genes associated with polymyxin resistance and other antimicrobial resistance‐related genes.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The high levels of resistance to polymyxin shown here, along with genetic similarities between some human and animal isolates, together suggest a need for sustained surveillance of this veterinary niche as a potential reservoir for resistant, clinically relevant bacteria in both animals and humans.</jats:p></jats:sec>
収録刊行物
-
- Veterinary Record
-
Veterinary Record 185 (7), 206-206, 2019-08
Wiley